Vaccine Response in the Immunocompromised Patient with Focus on Cellular Immunity
During the last few years, we have experienced a shift in how we evaluate the effectiveness of vaccines [...]
Main Authors: | Christina Bahrs, Nicole Harrison |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/6/882 |
Similar Items
-
WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
by: Massimo Franchini, et al.
Published: (2023-01-01) -
Immune Response of the Host and Vaccine Development
by: Ewa Długosz, et al.
Published: (2023-04-01) -
Metabolic Inflammation and Cellular Immunity
by: Sardar Sindhu, et al.
Published: (2023-06-01) -
Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes
by: Vivek P. Chavda, et al.
Published: (2022-07-01) -
Current Understanding of the Immune Response after COVID-19 Vaccination
by: Shunbin Ning, et al.
Published: (2024-02-01)